| 急性心肌梗死介入治疗进展 |
| |
| 引用本文： | 朱文玲.急性心肌梗死介入治疗进展[J].基础医学与临床,2001,21(2):97-100. |
| |
| 作者姓名： | 朱文玲 |
| |
| 作者单位： | 中国医学科学院中国协和医科大学北京协和医院, |
| |
| 摘 要： | 血栓形成确认为急性心肌梗死的病理基础后 ,80年代起再灌注治疗开创了急性心肌梗死 (ＡＭＩ)治疗的里程脾。多项临床试验证实静脉溶栓治疗显著降低了心肌梗死 (ＭＩ)的死亡率 ,大大改善了心肌梗死患者的预后。然而 ,静脉溶栓治疗仍有不足之处 ,如能接受溶栓治疗的患者仅 1/ 3,血管再通率只有 60 %～ 80 % ,而实际上溶栓后梗死相关血管冠状动脉造影达ＴＩＭＩ 3级血流 (即完全再灌注 )的仅50 %～ 55% ,ＴＩＭＩ 2级血流 (即部分再灌注 )虽达再灌注标准 ,但并不降低死亡率 ,Ａｎｄｅｒｓｏｎ等报告90ｍｉｎ梗死相关血管达ＴＩＭＩ 3级血流者 3…
|
| 关 键 词： | 急性心肌梗死 介入疗法 PTCA CABG 支架置入 |
| 文章编号： | 1001-6325(2001)02-0097-04 |
Progresses in interventional treatment of acute myocardial infarction |
| |
| ZHU Wen-ling.Progresses in interventional treatment of acute myocardial infarction[J].Basic Medical Sciences and Clinics,2001,21(2):97-100. |
| |
| Authors: | ZHU Wen-ling |
| |
| Institution: | ZHU Wen-ling |
| |
| Abstract: | Thrombolytic therapy has been proved to be effective in treating acute myocardial infarction (AMI), whereas the role of urgent percutaneous transluminal coronary angioplasty (PTCA) is disputed. Results of many clinical trials show that urgent PTCA, comparing with intravenous thrombolytic agents, has more advantages in increasing reperfusion rate, lowering mortality, the rate of reinfarct and bleeding. PTCA has gradually become a routine option in the treatment of AMI. This review focus mainly on PTCA intervention of AMI without thrombolysis, after thrombolytic success, and after thrombolytic failure. |
| |
| Keywords: | acute myocardial infarction percutaneous transluminal coronary angioplasty thrombolytic therapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
